Efficacy and Safety of Treatment With Ferric Carboxymaltose in Patients With Cirrhosis and Gastrointestinal Bleeding

Efficacy and Safety of Treatment With Ferric Carboxymaltose in Patients With Cirrhosis and Gastrointestinal Bleeding

Background: Patients with liver cirrhosis and gastrointestinal bleeding (GIB) often develop anemia. Ferric carboxymaltose (FCM) is an intravenous (i.v.) iron formulation approved for use in patients with iron deficiency with inadequate response to oral iron therapy or when oral iron cannot be used....

Full description

Bibliographic Details
Main Authors: Raquel Ballester-Clau, Gisela Torres Vicente, Mercedes Cucala Ramos, Carles Aracil Blanch, Josep Maria Miñana Calafat, Eva Pijoan Comas, Josep Maria Reñé Espinet, Montse Planella de Rubinat
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-04-01
Series:Frontiers in Medicine
Subjects:
liver cirrhosis
gastrointestinal bleeding (GIB)
intravenous iron (i.v.)
ferric carboxymaltose (FCM)
blood transfusion
Online Access:https://www.frontiersin.org/article/10.3389/fmed.2020.00128/full

Internet

https://www.frontiersin.org/article/10.3389/fmed.2020.00128/full

Similar Items